Catalyst Pharmaceuticals
CPRX
#3667
Rank
S$4.93 B
Marketcap
S$40.34
Share price
0.16%
Change (1 day)
32.49%
Change (1 year)

Market capitalization of Catalyst Pharmaceuticals (CPRX)

Market cap: S$4.93 Billion

As of June 2026 Catalyst Pharmaceuticals has a market cap of S$4.93 Billion. This makes Catalyst Pharmaceuticals the world's 3667th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Catalyst Pharmaceuticals from 2006 to 2026

End of year Market Cap

Year Marketcap Change
2026S$4.93 B28.47%
2025S$3.84 B10.39%
2024S$3.48 B47.06%
2023S$2.36 B-8.79%
2022S$2.59 B175.29%
2021S$0.94 B105.56%
2020S$0.45 B-12.28%
2019S$0.52 B93.98%
2018S$0.26 B-49.71%
2017S$0.53 B325.4%
2016S$0.12 B-56.13%
2015S$0.28 B5.85%
2014S$0.27 B102.82%
2013S$0.13 B506.97%
2012S$22.03 M-46.61%
2011S$41.26 M66.85%
2010S$24.73 M55.02%
2009S$15.95 M-55.92%
2008S$36.19 M-41.8%
2007S$62.19 M-32.91%
2006S$92.7 M

End of Day market cap according to different sources

On Jun 16th, 2026 the market cap of Catalyst Pharmaceuticals was reported to be:

S$4.92 Billion
by Nasdaq info icon info icon
S$4.92 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
S$724.24 B 14,570.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$189.78 B 3,744.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
S$198.02 B 3,911.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
S$2.30 B-53.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
S$1.05 M-99.98%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
S$13.66 B 176.74%๐Ÿ‡บ๐Ÿ‡ธ USA